Despite the promise of funding for clinical trials by some provinces, it will likely be years before they begin to do them in Canada: http://www.vancouversun.com/health/Researcher+cautions+trial+liberation+therapy+years+away/3442470/story.html#ixzz0xfdeLyLu. Then, assuming the trials are successful in identifying if/how CCSVI causes MS symptoms, how many more years will it be before our medical system gets geared up to treat the estimated 70,000 Canadians who now have MS along with the others who will have been diagnosed by then?
While it's understandable that the provinces wish to wait for more solid evidence before agreeing to Medicare coverage of CCSVI treatment for reasons of its possible impact on MS, why shouldn't assessment of MSers (who are now known to be likely to have CCSVI) and the treatment of blood flow abnormalities not be covered? At the very least, why not give Canadians the opportunity to do this as a precautionary measure at their own cost?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment